Pathophysiological mechanisms of symptoms development in Kawasaki disease
https://doi.org/10.34680/2076-8052.2024.2(136).221-229
Abstract
Kawasaki disease is an acute inflammatory disease that typically affects medium- to small-sized muscular arteries, especially the coronary vessels. In Novgorod region, from 2016 to 2023, Kawasaki disease was diagnosed in 5 children aged 3 months to 12 years. All children were admitted to the hospital with fever lasting from 5 to 8 days. Complete blood count and urinalysis were performed. Levels of transaminases, C-reactive protein, total protein, albumin, glucose, and coagulation tests were done in the serum. Samples of blood cultures for sterility were taken. The research plan included such instrumental methods as electrocardiography, echocardiography, chest radiography, ultrasound examination of the abdominal cavity and kidneys. 3 patients were diagnosed Kawasaki disease before the 10th day of illness. A 3-month-old baby was diagnosed Kawasaki disease on the 13th day. Another baby of the same age was diagnosed posthumously. The pathogenetic mechanisms of detected symptoms in children were considered.
About the Authors
T. I. OkonenkoRussian Federation
Veliky Novgorod
K. I. Mosicheva
Russian Federation
Veliky Novgorod
Ye. Ye. Rumyantsev
Russian Federation
Veliky Novgorod
I. A. Strikanov
Russian Federation
Veliky Novgorod
F. R. Kurbonaliev
Russian Federation
Veliky Novgorod
References
1. Rife E., Gedalia A. Kawasaki Disease: an Update // Current Rheumatology Reports. 2020. 22(10). 75. DOI: 10.1007/s11926-020-00941-4
2. Kirilina S.A. Sindrom Kavasaki u detej – aktual`noe [Kawasaki syndrom in children – current] // Paediatrician practice. 2021. 4. 5-11.
3. Rivas M. N., Arditi M. Kawasaki disease: pathophysiology and insights from mouse models // Nature Reviews Rheumatology. 2020. 16(7). 391-405. DOI: 10.1038/s41584-020-0426-0
4. Vaňková L., Bufka J., Křížková V. Pathophysiological and clinical point of view on Kawasaki disease and MIS-C // Pediatrics and Neonatology. 2023. 64(5). 495-504. DOI: 10.1016/j.pedneo.2023.05.002
5. Baranov А. А., Namazova-Baranova L. S., Tatochenko V. K., Basargina E. N., Bakradze M. D., Vishneva E. А., Selimzianova L. R., Kulichenko T. V., Vashakmadze N. D., Revunenkov G. V., Polyakova A.S., Fyodorova N. V. Obzor klinicheskih rekomendacij po bolezni/sindromu Kavasaki [Review of Clinical Recommendations for Kawasaki Disease/Syndrome] // Pediatricheskaya farmakologiya – Pediatric pharmacology. 2017. 14(2). 87-99. DOI: 10.15690/pf.v14i2.1723
6. Zariankina A. I. Limfadenopatiya u detej (vzglyad pediatra) [Lymphadenopathy in children (pediatric view)] // Meditsinskie novosti. 2018. 7. 25-29.
7. Yokota Sh., Nishioka K. Posledniye dostizheniya pediatricheskoy revmatologii v Yaponii: provospalitel'nyye tsitokiny kak terapevticheskaya mishen' pri bolezni Kavasaki, yuvenil'nom idiopaticheskom artrite i kriopirin-assotsiirovannom periodicheskom syndrome [Current Topics of Pediatric Rheumatology in Japan: Proinflammatory Cytokines as Therapeutic Targets for Kawasaki Disease, Systemic Juvenile Idiopathic Arthritis and Cryopyrin-associated periodic syndrome] // RMJ. 2017. 5. 380-386.
8. Takahashi K., Oharaseki T., Yokouchi Y., Hiruta N., Naoe S. Kawasaki disease as a systemic vasculitis in childhood // Annais of Vascular Diseases. 2010. 3(3). 173-181. DOI: 10.3400/avd.sasvp01003
9. Hedrich C. M., Schnabel A., Hospach T. Kawasaki Disease // Frontiers in Pediatrics. 2018. 6. 198. DOI: 10.3389/fped.2018.00198
10. Harnden A., Takahashi M., Burgner D. Kawasaki disease // BMJ. 2009. 338, b1514. 1133-1138. DOI: 10.1136/bmj.b1514
11. Liu X., Zhou K., Hua Y., Wu M., Liu L., Shao S., Wang C. Neurological involvement in Kawasaki disease: a retrospective study // Pediatric Rheumatology: online journal. 2020. 18(1). 61. DOI:10.1186/s12969-020-00452-7
12. Shalchi Z., Shirsalimi N., Sedighi I. Aseptic Meningitis, As the First Manifestation of Kawasaki Disease: A Case Report // Journal of Comprehensive Pediatrics. 2020. 11(4). e103101. DOI: 10.5812/compreped.103101
13. Peng Y., Yi Q. Incidence and timing of coronary thrombosis in Kawasaki disease patients with giant coronary artery aneurysm // Thrombosis Research. 2023. 221. 30-34. DOI: 10.1016/j.thromres.2022.11.014
14. Shutova E. Acetonemicheskij sindrom u detej: voprosy diagnostiki i terapii [Acetonemic syndrome in children: diagnosis and management] // Modern pediatrics. 2018. 2(90). 114-123. DOI: 10.15574/SP.2018.90.114
Review
For citations:
Okonenko T.I., Mosicheva K.I., Rumyantsev Ye.Ye., Strikanov I.A., Kurbonaliev F.R. Pathophysiological mechanisms of symptoms development in Kawasaki disease. Title in english. 2024;(2(136)):221-229. (In Russ.) https://doi.org/10.34680/2076-8052.2024.2(136).221-229